Posts by Wavemind

La personne sélectionnée sera en charge de la stratégie et les actions marcom du Biopôle Plus d’informations

Presentation of some of the company’s most advanced manufacturing facilities at Tolochenaz on 3 May 2018 Medtronic is among the world’s largest medical technology, services, and solutions companies. They deliver innovative services and solutions to hospitals, physicians, clinicians, and patients in approximately 160 countries, employing more than 84,000 people, including over 9,600 scientists and engineers.…

Genomic Health today announced the presentation of new data with the Oncotype DX® test at the 11th European Breast Cancer Conference (EBCC-11) in Barcelona, Spain The presentations underline the substantial real-world evidence available for Oncotype DX and reflect the growing adoption of the test across Europe to personalize and improve the quality of clinical decisions,…

regenHU will launch their new product @ the IDTechEX Show on 11-12 April 2018 in Berlin, Germany.   regenHU’s 3DDiscoveryTM Evolution, a revolutionary new generation of bio-printing equipment, is pushing the boundaries of tissue enginering and regenerative medicine to facilitate complex biofabrication of living tissues; one step closer to tissue and organ fabrication. The convergence of…

The Swiss start-up announced on 20 March that it will collaborate with the American multinational corporation to develop staining and analysis solutions for tumor samples.   Read the full press release here

Fort du succès enregistré à St Etienne en juin dernier, Orthomanufacture récidive à Yverdon-les-Bains les 20 et 21 juin 2018.   DeviceMed a interviewé les deux organisateurs, Philippe Planche et Olivier Vecten, pour faire le point sur cette deuxième édition. Article complet

This acquisition will add foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson’s disease Attachment Lundbeck announced on 16 March 2018 that it will acquire Prexton Therapeutics for up to EUR 905 million. Full press release

La qualité de vie du patient en cours de traitement “Qui pourra changer le monde dans lequel nous vivons?” «Construisons ensemble notre futur». C’est avec cette ambition et avec le désir de soutenir concrètement les personnes en traitement que le groupe pharmaceutique Debiopharm Group et la Fondation Inartis ont le plaisir de lancer un appel…

Prix BioAlps 2017 : la récompense d’une carrière Article du magazine HEPIA news – Mars 2018

Glenmark Pharmaceuticals announces it will enhance its capabilities in translational research by opening a new discovery centre at the Biopôle campus of Lausanne. View full article